Vpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophages

Journal of Virology

Volumn 82, Issue 15, 2008, Pages 7752-7756

  Fujita, Mikako ^a   Otsuka, Masami ^a   Miyoshi, Masami ^b   Khamsri, Boonruang ^b   Nomaguchi, Masako ^b   Adachi, Akio ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS PROTEIN; VPX PROTEIN;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SYNTHESIS; GENE; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 2; LYMPHOCYTE; MACROPHAGE; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; SITE DIRECTED MUTAGENESIS; VIRUS GENOME; VPX GENE; WILD TYPE;

AMINO ACID SUBSTITUTION; CELL LINE; DNA, VIRAL; HIV-2; HUMANS; LYMPHOCYTES; MACROPHAGES; MUTAGENESIS, SITE-DIRECTED; MUTATION, MISSENSE; REVERSE TRANSCRIPTION; VIRAL REGULATORY AND ACCESSORY PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 47749138633     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01003-07     Document Type: Article

References (25)

1. agm. J. Virol. 73:9992-9999.
2. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
3. Akari, H., T. Fukumori, S. Iida, and A. Adachi. 1999. Induction of apoptosis in Herpesvirus saimiri-immortalized T lymphocytes by blocking interaction of CD28 with CD80/CD86. Biochem. Biophys. Res. Commun. 263:352-356.
4. + T lymphocytes in cynomolgus macaques. Clin. Immunol. 91: 321-329.
5. SMM-PBj14. Nature 345:636-640.
6. SM. EMBO J. 15:6155-6165.
7. Fujita, M., A. Sakurai, A. Yoshida, M Miyaura, A. H. Koyama, K. Sakai, and A. Adachi. 2003. Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif. J. Virol. 77:1626-1632.
8. MAC gag capsid region. J. Virol. 75:10527-10531.
9. SM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Retrovirology 4:2.
10. Guyader, M., M. Emerman, L. Montagnier, and K. Peden. 1989. Vpx mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes. EMBO J. 8:1169-1175.
11. Henderson, L. E., R. C. Sowder, T. D. Copeland, R. E. Benveniste, and S. Oroszlan. 1988. Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2. Science 241:199-201.
12. MAC. J. Virol. 62:3501-3505.
13. Kawamura, M., H. Sakai, and A. Adachi. 1994. Human immunodeficiency virus Vpx is required for the early phase of replication in peripheral blood mononuclear cells. Microbiol. Immunol. 38:871-878.
14. Khamsri, B., F. Murao, A. Yoshida, A. Sakurai, T. Uchiyama, H. Shirai, Y. Matsuo, M. Fujita, and A. Adachi. 2006. Comparative study on the structure and cytopathogenic activity of HIV Vpr/Vpx proteins. Microbes Infect. 8:10-15.
15. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66: 2232-2239.
16. Koh, K. B., M. Fujita, and A. Adachi. 2000. Elimination of HIV-1 plasmid DNA from virus samples obtained from transfection by calcium-phosphate co-precipitation. J. Virol. Methods 90:99-102.
17. Lebkowski, J. S., S. Clancy, and M. P. Calos. 1985. Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression. Nature 317:169-171.
18. Le Rouzic, E., N. Belaidouni, E. Estrabaud, M. Morel, J.-C. Rain, C. Transy, and F. Margottin-Goguet. 2007. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle 6:182-188.
19. O'Doherty, U., W. J. Swiggard, and M. H. Malim. 2000. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74:10074-10080.
20. Pancio, H. A., N. V. Heyden, and L. Ratner. 2000. The C-terminal proline-rich tail of human immunodeficiency virus type 2 Vpx is necessary for nuclear localization of the viral preintegration complex in nondividing cells. J. Virol. 74:6162-6167.
21. Ueno, F., H. Shiota, M. Miyaura, A. Yoshida, A. Sakurai, J. Tatsuki, A. H. Koyama, H. Akari, A. Adachi, and M. Fujita. 2003. Vpx and Vpr proteins of HIV-2 up-regulate the viral infectivity by a distinct mechanism in lymphocytic cells. Microbes Infect. 5:387-395.
22. Willey, R. L., D. H. Smith, L. A. Lasky, T. S. Theodore, P. L. Earl, B. Moss, D. J. Capon, and M. A Martin. 1988. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62:139-147.
23. Yee, J. K., A. Miyanohara, P. LaPorte, K. Bouic, J. C. Burns, and T. Friedmann. 1994. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA 91:9564-9568.
24. Yu, X. F., S. Ito, M. Essex, and T. H. Lee. 1988. A naturally immunogenic virion-associated protein specific for HIV-2 and SIV. Nature 335:262-265.
25. Yu, X. F., Q. C. Yu, M. Essex, and T. H. Lee. 1991. The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophages. J. Virol. 65:5088-5091.